(Q48608872)

13 February 2018

title

Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride. (English)

1 reference

13 February 2018

author name string

Robert G Hahn

1

1 reference

13 February 2018

Tim Fagerström

2

1 reference

13 February 2018

Teuvo L J Tammela

3

1 reference

13 February 2018

Oncko Van Vierssen Trip

4

1 reference

13 February 2018

Hans Olav Beisland

5

1 reference

13 February 2018

Annette Duggan

6

1 reference

13 February 2018

Betsy Morrill

7

1 reference

13 February 2018

publication date

1 March 2007

1 reference

13 February 2018

published in

BJU International

1 reference

13 February 2018

volume

99

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

587-594

1 reference

13 February 2018

Factors influencing morbidity in patients undergoing transurethral resection of the prostate.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Finasteride: a long-term follow-up in the treatment of recurrent hematuria associated with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Preoperative administration of chlormadinone acetate reduces blood loss associated with transurethral resection of the prostate: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Pre-surgical finasteride therapy in patients treated endoscopically for benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Influence of variations in blood haemoglobin concentration on the calculation of blood loss and volumetric irrigating fluid balance during transurethral resection of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Effects of finasteride on vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06619.X

10.1111/J.1464-410X.2006.06619.X

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018